Welcome to LookChem.com Sign In|Join Free
  • or
L-Ala-NH2-DNP-D-pentadecylglycine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1234357-62-0

Post Buying Request

1234357-62-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1234357-62-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1234357-62-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,4,3,5 and 7 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1234357-62:
(9*1)+(8*2)+(7*3)+(6*4)+(5*3)+(4*5)+(3*7)+(2*6)+(1*2)=140
140 % 10 = 0
So 1234357-62-0 is a valid CAS Registry Number.

1234357-62-0Downstream Products

1234357-62-0Relevant academic research and scientific papers

Mechanistic analysis of muraymycin analogues: A guide to the design of MraY inhibitors

Tanino, Tetsuya,Al-Dabbagh, Bayan,Mengin-Lecreulx, Dominique,Bouhss, Ahmed,Oyama, Hiroshi,Ichikawa, Satoshi,Matsuda, Akira

, p. 8421 - 8439 (2012/02/13)

The systematic structure-activity relationship (SAR) of the muraymycins (MRYs) using an Ugi four-component reaction (U4CR) was investigated. The impact of the lipophilic substituent on antibacterial activity was significant, and the analogues 8 and 9 having a lipophilic side chain exhibited good activity against a range of Gram-positive bacterial pathogens, including MRSA and VRE. Further investigation of compounds 8 and 9 revealed these analogues to be selective inhibitors of the MraY transferase and nontoxic to HepG2 cells. The SAR of the accessory urea-peptide moiety indicated that it could be simplified. Our SAR study of the MRYs suggests a probable mechanism for inhibition of the MraY, where the inner moiety of the urea-dipeptide motif interacts with the carbohydrate recognition domain in the cytoplasmic loop 5. The predicted binding model would provide further direction toward the design of potent MraY inhibitors. This study has set the stage for the generation of novel antibacterial "lead" compounds based on MRYs. (Figure presented)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1234357-62-0